Case File
efta-02651957DOJ Data Set 11OtherEFTA02651957
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02651957
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
Thursday, April 20, 2017 12:02 AM
To:
Jeffrey Epstein
Subject:
Plants
H=
Not sure how to think about the=neurobiology of plants. There is a robust bunch of literature on how plant=cells are
stressed, how they respond and how they build biological resilie=ce along the way. Because they are sessile and can't
just call their d=c for a prescription, whatever they do has to be relatively simple and par= of a very basic process that
either displaces, overcomes, outdoes or modi=ies a stressor to make it manageable.
Plants don't have nerves per se but they have cells that behave in a =imilar way for similar purposes as our nerves.
Plants do use what we call =eurotransmitters
catecholamines like dopamine and norepi- they have t=ns of
acetylcholine and the same degradation pathways, and even the same g=utamate pathways and receptors humans do.
And, more.
Classes of movements are common to almost all plants, just=as with humans. Darwin described them pretty well.
Breakdown in these move=ent systems can look similar in humans - we just have more types of motion=to deal with
than plants ... like when we get dopamine deficient in Parkin=on or atrophied alpha motor neurons in ALS. They have
similar problems in =heir motor systems, and usually they overcome them if they can adapt to or=beat the stressor.
Plants also have =emory (used mostly for growth and reproduction) and some think different t=pes of cognition too.
While glutamate is a big player in that process, it =sn't the only one. Some of the chemicals have also evolved to serve
si=ilar functions, including a lot of similarity in core function between chl=rophyll and melanin. Chlorophyll serves to
capture light and create energy= the core function require to sustain a sessile plant. Melanin becomes dop=mine, which
allows humans to move and somehow plays other more important r=les that we don't yet understand as the
melanocytes are derived from n=ural crest cells (high priced embryologic real estate...)
Stressors to motor or cognitive processes include(th=re are more):
Water
Sodium
Temperature
Heavy metals
Pathogens (bugs)
Also, light is v=ry toxic to roots and certain type of internal cells in vascular plants.</=pan>
So c=n plants get Alzheimer-like protein aggregation diseases that slowly disru=t cognitive function to the point of
death?
Can they get disordered movement dis=rders like Parkinson where they lack a particular chemical or wasting dise=ses
like ALS where their locomotion capacity is slowly diminished.<=div> =span style="font-family:arial,sans-seritfont-
size:12.8px">
</=iv>
<=pan style="font-family:arial,sans-seritfont-size:12.8px">Yes, they do. =nd many more diseases too.
EFTA_R1_01894694
EFTA02651957
In the case of acidified soil, aluminum (normally no= particularly bothersome unless in super high concentration) acts as
a str=ssor in a very similar way to what we see in alzheimer pathology. Using me=abolic pathways, root absorption of
other elements, or even transfer of nu=rients from root symbionts, plant cells that are not consumed by the stres= can
manage, adapt or clear the stressor. The pathology in a very specific=part of the root appears very similar to
plaques/tangles, as does the resu=ting behavior in plants.
In humans, there is no viable use for aluminum and toxic=ty has long been known. It is unlikely there is much concern on
an environ=ental basis, but maybe. I think there is probably enough silica . silicate= in our water to balance in out. But on
a tiny scale, focused hits of alum=num can be very deadly and especially when they are in an acidic environme=t.
Rec=ntly, a common type of drug (PPI / proton pump inhibitor) taken for heartb=rn, acid reflux or peptic ulcers was
correlated w Alzheimer (Sample from 7=,000 people over age 75 from 2004-2011 in Germany). Specifically, patients=on
PPI are thought to have a 44% increased risk of dementia. But in my vie= the mechanism doesn't quite make sense -
what does make sense is that=patients with heartburn reflux or ulcers also take antacids. And the most =ommon
ingredient in antacids is aluminum. Not just regular aluminum but st=aight to the most acidified part of the human body,
so that the aluminum b=comes quite reactive. Some of the aluminum will be uptaken by the bidirect=onal
parasympathetics (vagal) and transported into the nervous system, but=some of the aluminum will also pass through
the gut and upset both the mic=obiome and the gut (enteric) nervous system as well. It doesn't take m=ch and it doesn't
even have to stay for very long, but if you are taki=g aluminum (or other active heavy metal) almost every day for many
years, =ou will pay the price - even if your body can find a way to remove it pret=y quickly. Meanwhile the inflammation
in the cells will continue.</=iv> apan style="font-family:arial,sans-serif;font-size:12.8px">
I do think ther= is a similar situation happening in the enteric nervous system that is th= trigger for Parkinsons - which is
why there are gastric, integumentary an= gut symptoms very early and persistently throughout. My suspicion is that=it
affects either the microbiome and/or eventually the dopmainergic neuron= of the gut. Over time, this will migrate up
the vagus or along some melan=n/dopaminergic pathway to make trouble. Whatever pathway that allowed the =elanin
to migrate to the brain the first place is allowing the stressor to=follow, probably bound to some form of co-variable.
MOre later on ALS.
But what d= plants do, how do they do it and why aren't we doing it?
=div class="gmail_default" style="font-family:verdana,sans-serif">
<=iv class="gmail_default" style="font-family:verdana,sans-serir>I've collected =early 100 papers in the literature. We
will have to connect all of the dot= because none of the plant scientists are thinking about human science, an= vice
versa. Perhaps the most elegant experiments were done by Darwin hims=lf.
ar>
To=ight I am curating the papers and putting them into a google drive that yo= can click on anytime.
I will try to make a file where you can upload documents t= and send instructions in just a bit.
This is too elegant and simple but my guess=is that it will get crushed by pharma and traditional science. Plus everyo=e
who wants to class action lawsuit all of the antacid companies.</=iv> <=pan style="font-family:arial,sans-seritfont-
size:12.8px">
More in a bit.<=span>
</=pan>
2
EFTA_R1_01894695
EFTA02651958
=/div>
adiv>
=span styleefont-family:anal,sans-sentfont-size:12.8pe>
<1=iv>
EFTA_R1_01894696
EFTA02651959
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2651957Phone
2651958Phone
2651959Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.